Press Release: Klogene Therapeutics : A Boost of Klotho Protein Level Has Therapeutic Potential in Amyotrophic Lateral Sclerosis (ALS), Also Known as Lou Gehrig's Disease

Press Release: Klogene Therapeutics : Klogene and Boston University Scientists are First to use CRISPR for Activation of the Life Extension and Cognition Enhancing Klotho Gene

Press Release: Klogene Therapeutics : Klogene and Kogenix announce merger